Home
ANIK
ANIK News

Latest Anika Therapeutics Inc. (ANIK) News on October 30, 2025

AI will 'amplify, not replace' human performance: Workday CEO

Yahoo Finance Video

4 days ago

AI will 'amplify, not replace' human performance: Workday CEO

'Premature to signal the all-clear': Markets cheered the CPI print — but Main Street isn’t feeling the relief

Yahoo Finance

4 days ago

'Premature to signal the all-clear': Markets cheered the CPI print — but Main Street isn’t feeling the relief

Grant Cardone Lays Out Why His Bitcoin Real Estate Hybrid Model Will Crush REITs

Benzinga

4 days ago

Grant Cardone Lays Out Why His Bitcoin Real Estate Hybrid Model Will Crush REITs

Media Advisory - Monday, October 27, 2025

CNW Group

4 days ago

Media Advisory - Monday, October 27, 2025

Israel insists it calls shots in Gaza despite truce

AFP

4 days ago

Israel insists it calls shots in Gaza despite truce

Bitcoin’s Path To $120,000 Could Be Delayed as Illiquid Supply Shrinks

BeInCrypto

4 days ago

Bitcoin’s Path To $120,000 Could Be Delayed as Illiquid Supply Shrinks

Walmart’s award-winning $168 Viktor & Rolf perfume with 4,300+ perfect ratings is on sale for only $78

TheStreet

4 days ago

Walmart’s award-winning $168 Viktor & Rolf perfume with 4,300+ perfect ratings is on sale for only $78

Could Investing $10,000 in Rigetti Computing Make You a Millionaire?

Motley Fool

4 days ago

Could Investing $10,000 in Rigetti Computing Make You a Millionaire?

Anika to Issue Third Quarter 2025 Financial Results on Wednesday, November 5, 2025

GlobeNewswire

7 days ago

Anika to Issue Third Quarter 2025 Financial Results on Wednesday, November 5, 2025

Gourmey snaps up cultivated-protein peer VitalMeat

Just Food

15 days ago

Gourmey snaps up cultivated-protein peer VitalMeat

2025 Rawlings Gold Glove Award® Finalists Announced

PR Newswire

15 days ago

2025 Rawlings Gold Glove Award® Finalists Announced

HI-CHEW® Unleashes a Frightfully Fun Halloween Pop-Up in SoCal with the HI-CHEW® House of Mystery

PR Newswire

15 days ago

HI-CHEW® Unleashes a Frightfully Fun Halloween Pop-Up in SoCal with the HI-CHEW® House of Mystery

Homecoming Hero: Justin Moore Surprises Hometown High School with New Bobcat Mower

PR Newswire

15 days ago

Homecoming Hero: Justin Moore Surprises Hometown High School with New Bobcat Mower

TruHearing Survey Reveals Strong Provider Network is Key to Closing Hearing Health Gaps

PR Newswire

15 days ago

TruHearing Survey Reveals Strong Provider Network is Key to Closing Hearing Health Gaps

CJ BIO Showcases Science-Backed Nutrition Solutions at SSG 2025

PR Newswire

15 days ago

CJ BIO Showcases Science-Backed Nutrition Solutions at SSG 2025

Wm. Paul Young Pens Sequel to the Worldwide Phenomenon, The Shack

PR Newswire

15 days ago

Wm. Paul Young Pens Sequel to the Worldwide Phenomenon, The Shack

Energy Global

15 days ago

EU expands investments in Central Asia’s hydropower sector

Orthopedic Digit Implants Market Report 2025-2033, with Profiles of Extremity Medical, Stryker, Zimmer, Smith & Nephew, Depuy, Arthrex, Acumed, Anika Therapeutics, VILEX, and Paragon 28

GlobeNewswire

22 days ago

Orthopedic Digit Implants Market Report 2025-2033, with Profiles of Extremity Medical, Stryker, Zimmer, Smith & Nephew, Depuy, Arthrex, Acumed, Anika Therapeutics, VILEX, and Paragon 28

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

2 months ago

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Anika to Issue Second Quarter 2025 Financial Results on Wednesday, July 30, 2025

GlobeNewswire

3 months ago

Anika to Issue Second Quarter 2025 Financial Results on Wednesday, July 30, 2025

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

5 months ago

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Sidoti Events, LLC's Virtual May Micro-Cap Conference

ACCESS Newswire

5 months ago

Sidoti Events, LLC's Virtual May Micro-Cap Conference

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

6 months ago

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Company News for May 12, 2025

Zacks

6 months ago

Company News for May 12, 2025

MT Newswires

6 months ago

Barrington Adjusts Anika Therapeutics Price Target to $19 From $20, Maintains Outperform Rating

Anika Therapeutics First Quarter 2025 Earnings: Misses Expectations

Simply Wall St.

6 months ago

Anika Therapeutics First Quarter 2025 Earnings: Misses Expectations

Anika Therapeutics Inc (ANIK) Q1 2025 Earnings Call Highlights: Strategic Growth Amidst Revenue ...

GuruFocus.com

6 months ago

Anika Therapeutics Inc (ANIK) Q1 2025 Earnings Call Highlights: Strategic Growth Amidst Revenue ...

Anika Therapeutics (ANIK) Reports Q1 Loss, Misses Revenue Estimates

Zacks

6 months ago

Anika Therapeutics (ANIK) Reports Q1 Loss, Misses Revenue Estimates

Associated Press Finance

6 months ago

Anika: Q1 Earnings Snapshot

Anika Reports First Quarter 2025 Financial Results

GlobeNewswire

6 months ago

Anika Reports First Quarter 2025 Financial Results

Earnings To Watch: Anika Therapeutics Inc (ANIK) Reports Q1 2025 Result

GuruFocus.com

6 months ago

Earnings To Watch: Anika Therapeutics Inc (ANIK) Reports Q1 2025 Result

Anika to Participate in the Sidoti Virtual Investor Conference

GlobeNewswire

6 months ago

Anika to Participate in the Sidoti Virtual Investor Conference

Is the Options Market Predicting a Spike in Anika Therapeutics Stock?

Zacks

6 months ago

Is the Options Market Predicting a Spike in Anika Therapeutics Stock?

Anika to Issue First Quarter 2025 Financial Results on Friday, May 9, 2025

GlobeNewswire

6 months ago

Anika to Issue First Quarter 2025 Financial Results on Friday, May 9, 2025

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

7 months ago

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Are Options Traders Betting on a Big Move in Anika Therapeutics (ANIK) Stock?

Zacks

7 months ago

Are Options Traders Betting on a Big Move in Anika Therapeutics (ANIK) Stock?

Anika Therapeutics Full Year 2024 Earnings: Misses Expectations

Simply Wall St.

8 months ago

Anika Therapeutics Full Year 2024 Earnings: Misses Expectations

Thomson Reuters StreetEvents

8 months ago

Q4 2024 Anika Therapeutics Inc Earnings Call

Anika Therapeutics Inc (ANIK) Q4 2024 Earnings Call Highlights: Navigating Growth and Challenges

GuruFocus.com

8 months ago

Anika Therapeutics Inc (ANIK) Q4 2024 Earnings Call Highlights: Navigating Growth and Challenges

Anika Therapeutics (ANIK) Reports Q4 Loss, Tops Revenue Estimates

Zacks

8 months ago

Anika Therapeutics (ANIK) Reports Q4 Loss, Tops Revenue Estimates

MT Newswires

8 months ago

Anika Therapeutics Q4 Swings to Adjusted Loss, Revenue Rises -- Shares Drop After Hours

Associated Press Finance

8 months ago

Anika: Q4 Earnings Snapshot

Anika Reports Fourth Quarter and Full Year 2024 Financial Results

GlobeNewswire

8 months ago

Anika Reports Fourth Quarter and Full Year 2024 Financial Results

MT Newswires

8 months ago

Anika Therapeutics Completes Divestiture of Parcus Medical to Medacta

Anika Completes Divestiture of Parcus Medical

GlobeNewswire

8 months ago

Anika Completes Divestiture of Parcus Medical

Is Anika Therapeutics, Inc. (ANIK) the Best Small Cap Pharma Stocks to Buy Now?

Insider Monkey

8 months ago

Is Anika Therapeutics, Inc. (ANIK) the Best Small Cap Pharma Stocks to Buy Now?

Anika to Issue Fourth Quarter and Year-End 2024 Financial Results on Wednesday, March 12, 2025

GlobeNewswire

8 months ago

Anika to Issue Fourth Quarter and Year-End 2024 Financial Results on Wednesday, March 12, 2025

Anika To Present at the Canaccord Genuity 2025 Musculoskeletal Conference

GlobeNewswire

8 months ago

Anika To Present at the Canaccord Genuity 2025 Musculoskeletal Conference

Are Investors Undervaluing Anika Therapeutics, Inc. (NASDAQ:ANIK) By 48%?

Simply Wall St.

9 months ago

Are Investors Undervaluing Anika Therapeutics, Inc. (NASDAQ:ANIK) By 48%?

Strength Seen in Stoke Therapeutics (STOK): Can Its 9.4% Jump Turn into More Strength?

Zacks

9 months ago

Strength Seen in Stoke Therapeutics (STOK): Can Its 9.4% Jump Turn into More Strength?

We Think Anika Therapeutics (NASDAQ:ANIK) Can Easily Afford To Drive Business Growth

Simply Wall St.

10 months ago

We Think Anika Therapeutics (NASDAQ:ANIK) Can Easily Afford To Drive Business Growth

Anika To Participate in 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

10 months ago

Anika To Participate in 43rd Annual J.P. Morgan Healthcare Conference

Sidoti Events, LLC's Virtual December Small-Cap Conference

ACCESSWIRE

a year ago

Sidoti Events, LLC's Virtual December Small-Cap Conference

Anika To Participate in December 2024 Investor Conferences

GlobeNewswire

a year ago

Anika To Participate in December 2024 Investor Conferences

Anika Therapeutics Third Quarter 2024 Earnings: Misses Expectations

Simply Wall St.

a year ago

Anika Therapeutics Third Quarter 2024 Earnings: Misses Expectations

Anika Therapeutics Inc (ANIK) Q3 2024 Earnings Call Highlights: Strategic Shifts Amid Revenue ...

GuruFocus.com

a year ago

Anika Therapeutics Inc (ANIK) Q3 2024 Earnings Call Highlights: Strategic Shifts Amid Revenue ...

Arthrosurface Returns to it Roots Following Divestiture from Anika Therapeutics

PR Newswire

a year ago

Arthrosurface Returns to it Roots Following Divestiture from Anika Therapeutics

Anika Therapeutics (ANIK) Reports Q3 Loss, Lags Revenue Estimates

Zacks

a year ago

Anika Therapeutics (ANIK) Reports Q3 Loss, Lags Revenue Estimates

Associated Press Finance

a year ago

Anika: Q3 Earnings Snapshot

Anika Reports Third Quarter 2024 Financial Results

GlobeNewswire

a year ago

Anika Reports Third Quarter 2024 Financial Results

Anika Announces Strategic Update of Business with Sale of Arthrosurface and Plan to Divest Parcus Medical

GlobeNewswire

a year ago

Anika Announces Strategic Update of Business with Sale of Arthrosurface and Plan to Divest Parcus Medical

Investors in Anika Therapeutics (NASDAQ:ANIK) have unfortunately lost 61% over the last five years

Simply Wall St.

a year ago

Investors in Anika Therapeutics (NASDAQ:ANIK) have unfortunately lost 61% over the last five years

Anika Therapeutics Inc (ANIK) Q3 2024: Everything You Need To Know Ahead Of Earnings

GuruFocus.com

a year ago

Anika Therapeutics Inc (ANIK) Q3 2024: Everything You Need To Know Ahead Of Earnings

Anika Announces Third Quarter 2024 Results Conference Call Date

GlobeNewswire

a year ago

Anika Announces Third Quarter 2024 Results Conference Call Date

Anika Therapeutics Inc (ANIK) Q2 2024 Earnings Call Highlights: Navigating Revenue Challenges ...

GuruFocus.com

a year ago

Anika Therapeutics Inc (ANIK) Q2 2024 Earnings Call Highlights: Navigating Revenue Challenges ...

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

a year ago

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

a year ago

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

a year ago

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Anika Therapeutics, Inc. (NASDAQ:ANIK) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates

Simply Wall St.

a year ago

Anika Therapeutics, Inc. (NASDAQ:ANIK) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates

Anika Therapeutics, Inc. (ANIK): Are Hedge Funds Bullish on This Caligan Partners-Approved Stock?

Insider Monkey

a year ago

Anika Therapeutics, Inc. (ANIK): Are Hedge Funds Bullish on This Caligan Partners-Approved Stock?

Anika Therapeutics (ANIK) Q2 Earnings Lag Estimates

Zacks

a year ago

Anika Therapeutics (ANIK) Q2 Earnings Lag Estimates

Associated Press Finance

a year ago

Anika: Q2 Earnings Snapshot

Anika Reports Second Quarter 2024 Financial Results

GlobeNewswire

a year ago

Anika Reports Second Quarter 2024 Financial Results

Anika to Issue Second Quarter 2024 Financial Results on Thursday, August 8, 2024

GlobeNewswire

a year ago

Anika to Issue Second Quarter 2024 Financial Results on Thursday, August 8, 2024

We're Not Worried About Anika Therapeutics' (NASDAQ:ANIK) Cash Burn

Simply Wall St.

a year ago

We're Not Worried About Anika Therapeutics' (NASDAQ:ANIK) Cash Burn

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

a year ago

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

MT Newswires

a year ago

Anika Therapeutics Extends Availability of Integrity Implant System

Anika Announces Full Market Release of the Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Scaffold for Rotator Cuff and Other Tendon Repairs

GlobeNewswire

a year ago

Anika Announces Full Market Release of the Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Scaffold for Rotator Cuff and Other Tendon Repairs

FDA panel votes to recommend Eli Lilly's Alzheimer's drug

Yahoo Finance Video

a year ago

FDA panel votes to recommend Eli Lilly's Alzheimer's drug

GlobeNewswire

a year ago

Chu Vision Institute Unveils Comprehensive Guide to LASIK Recovery and Aftercare, Pioneering Patient Care in Minneapolis

California seeks company profits in Big Oil climate lawsuit

Reuters

a year ago

California seeks company profits in Big Oil climate lawsuit

USA TODAY

a year ago

S&P 500, Nasdaq post record closing highs; Fed meeting, CPI ahead

Dutch Bros Inc. Announces Launch of Secondary Public Offering of Class A Common Stock

Business Wire

a year ago

Dutch Bros Inc. Announces Launch of Secondary Public Offering of Class A Common Stock

Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis

GlobeNewswire

a year ago

Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis

Global Polycaprolactone Market to Record Revenue Worth US$ 1535.5 Mn by 2034; Anticipated to Experience CAGR of 10.3% During 2024 – 2034; states TNR, The Niche Research

GlobeNewswire

a year ago

Global Polycaprolactone Market to Record Revenue Worth US$ 1535.5 Mn by 2034; Anticipated to Experience CAGR of 10.3% During 2024 – 2034; states TNR, The Niche Research

Media Advisory: Federal Housing Finance Agency Director Sandra Thompson Visits Affordable Apartment Complex in Dallas

Business Wire

a year ago

Media Advisory: Federal Housing Finance Agency Director Sandra Thompson Visits Affordable Apartment Complex in Dallas

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

a year ago

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

MT Newswires

a year ago

Anika Therapeutics Approves $40 Million Share Repurchase Program

Anika Enters into Cooperation Agreement with Caligan Partners

GlobeNewswire

a year ago

Anika Enters into Cooperation Agreement with Caligan Partners

Anika Therapeutics First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.

a year ago

Anika Therapeutics First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Anika Therapeutics, Inc. (NASDAQ:ANIK) Q1 2024 Earnings Call Transcript

Insider Monkey

a year ago

Anika Therapeutics, Inc. (NASDAQ:ANIK) Q1 2024 Earnings Call Transcript

Thomson Reuters StreetEvents

a year ago

Q1 2024 Anika Therapeutics Inc Earnings Call

GuruFocus.com

a year ago

Anika Therapeutics Inc (ANIK) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth and ...

Associated Press Finance

a year ago

Anika: Q1 Earnings Snapshot

Anika Announces CFO Transition

GlobeNewswire

a year ago

Anika Announces CFO Transition

Anika Reports First Quarter 2024 Financial Results

GlobeNewswire

a year ago

Anika Reports First Quarter 2024 Financial Results

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

a year ago

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Anika Therapeutics (NASDAQ:ANIK) shareholders have endured a 37% loss from investing in the stock three years ago

Simply Wall St.

2 years ago

Anika Therapeutics (NASDAQ:ANIK) shareholders have endured a 37% loss from investing in the stock three years ago

Anika to Issue First Quarter 2024 Financial Results on Wednesday, May 8, 2024

GlobeNewswire

2 years ago

Anika to Issue First Quarter 2024 Financial Results on Wednesday, May 8, 2024

Is DexCom (DXCM) Outperforming Other Medical Stocks This Year?

Zacks

2 years ago

Is DexCom (DXCM) Outperforming Other Medical Stocks This Year?

Share on Social Networks: